Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $2.09 Million - $2.48 Million
-28,714 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $14,409 - $17,385
196 Added 0.69%
28,714 $2.44 Million
Q1 2019

May 09, 2019

SELL
$63.56 - $88.17 $454,644 - $630,680
-7,153 Reduced 20.05%
28,518 $2.45 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $2.09 Million - $2.49 Million
35,671 New
35,671 $2.27 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Emory University Portfolio

Follow Emory University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

News

Stay updated on Emory University with notifications on news.